It also inhibits proliferation and EMT while promoting apoptosis through RB1 downregulation in non-small-cell lung cancer (NSCLC) [71, 85], and has been found to target TRIM44 to curb cancer cell proliferation, migration, and invasion [54]. Here, RB1 is linked to non-small cell lung carcinoma.